Permanent radiotherapy implants reduce risk of prostate cancer recurrence after five years
Results from a randomised controlled trial to compare the use of permanent radioactive implants (brachytherapy) with dose-escalated external beam radiotherapy in patients with prostate cancer show that the men who received ...
Apr 26, 2015
1
17